Afternoon Symposia

Learn about clinical breakthroughs and advances in patient care during the educational symposia at the Society of Critical Care Medicine's (SCCM) 47th Critical Care Congress. Each stimulating session is presented by leading experts in critical care and offers a thorough analysis of the developments and issues affecting most intensive care unit (ICU) environments.

These symposia will be held Monday, February 26, 2018, at the Henry B. Gonzalez Convention Center. Seating is on a first-come, first-served basis. These sessions are complimentary for all Congress registrants, and no additional registration is needed to attend. The sessions will start promptly at 12:30 p.m.

A limited number of boxed lunches will be available to symposia attendees only beginning at 12:00 p.m.​​​​​​​​​​​​​

 

 Parenteral Nutrition

 

Parenteral Nutrition in the Critically Ill: Appropriate Administration of Intravenous Lipid Emulsions
Supported by an educational grant from Fresenius Kabi USA, LLC
Moderator: Robert G. Martindale​

Room: Hemisfair Ballroom C1, Henry B. Gonzalez Convention Center

Sessions

  • Critically Ill Patients’ Nutrition Requirements: Are Our Concepts Now Changing?
    Robert G. Martindale, MD, PhD
  • Efficacy and Safety Data of Intravenous Lipid Emulsions: Where Are We in 2018?
    Ryan Hurt, MD, PhD
  • Guideline Recommendations for Parenteral Nutrition and Intravenous Lipid Emulsions for the ICU Patient
    Stephen McClave​. MD
Learning Objectives
  • Devise treatment plans that incorporate lipid emulsions into parenteral nutrition, accounting for differences in fatty acids and patient clinical factors
  • Compare and contrast the fatty acid composition, efficacy, and safety of intravenous lipid emulsion formulations
  • Formulate processes to ensure that intravenous lipid emulsions are administered according to evidence and guidelines


 

 Antiplatelet and Anticoagulants

 

Challenges of Using Antiplatelet and Anticoagulant Agents in the Critically Ill
Supported by an educational grant from Portola Pharmaceuticals
Moderator: William E. Dager 

Room: Hemisfair Ballroom C2, Henry B. Gonzalez Convention Center

Sessions

  • Non-Vitamin K Antagonist Oral Anticoagulants
    John J. Lewin III, MBA, PharmD, FCCM
  • New Antiplatelets Agents: Thyenopyridines
    William E. Dager
  • Emergent Management of Bleeding and Reversal of Anticoagulant and Antiplatelet Agents
    ​Truman J. MIlling, MD

Learning Objectives

  • Review the unique characteristics of the new antiplatelet and anticoagulant  agents and understand indications and contraindications for their use
  • Explore benefits and potential risks of antiplatelet and anticoagulant agents
  • Discuss approaches to managing critical bleeding and reversal strategies to chemical antiplatelet and anticoagulant agents